MEF2 transcription factors: developmental regulators and emerging cancer genes

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Myocyte enhancer factor 2 (MEF2) transcription factors are crucial regulators of cell differentiation, proliferation, apoptosis, migration, shape, and metabolism.
• These factors are involved in the development of multiple cell types, including muscle, cardiac, skeletal, vascular, neural, blood, and immune cells.
• Altered MEF2 activity is implicated in human diseases and has emerged as a factor in cancer development.

Purpose of the Study:

• To review the molecular interactions of MEF2 proteins and their impact on cellular and organismal phenotypes.
• To discuss the emerging roles of MEF2 proteins as oncogenes and tumor suppressors in cancer.
• To highlight similarities and differences among MEF2 family proteins, with a specific focus on MEF2B functions.

Main Methods:

• Survey of molecular interactions of MEF2 proteins.
• Analysis of MEF2 effects on cellular and organismal phenotypes.
• Review of genome-scale technologies for identifying MEF2 target gene sets.

Main Results:

• MEF2 proteins function as critical nodes in complex regulatory networks.
• MEF2B exhibits unique functions compared to its paralogs, particularly in non-Hodgkin lymphomas.
• Comprehensive MEF2 target gene sets have been identified, enhancing understanding of their regulatory roles.

Conclusions:

• MEF2 proteins play diverse roles in normal cellular development and are implicated in disease pathogenesis.
• The dual role of MEF2 proteins as oncogenes and tumor suppressors in cancer warrants further investigation.
• MEF2B's distinct functions highlight the need for family-specific analysis in understanding MEF2 roles in health and disease.